NEW YORK (CBS.MW) -- SuperGen Inc. said it has received approval of its abbreviated new drug application for its Paclitaxel injection in a number of dosages from the Food and Drug Administration.

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/f3da95/market_of_paclitax) has announced the addition of the "Market of ...

Cardiovascular magnetic resonance imaging compared to echocardiogram for detecting doxorubicin-induced cardiotoxicity. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This ...

NEW YORK, Aug. 19 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: What's more, paclitaxel injection has to get into hospitals through ...

The certification is a milestone for Kexing Biopharm, whose first drug for cancer therapy, Paclitaxel for Injection (Albumin Bound) , can now be registered in the EU as the company overcomes the ...

Cardiff Oncology, Inc. (NASDAQ:CRDF) announced groundbreaking Phase 1b clinical trial results for its PLK1 inhibitor ...

Researchers compare relacorilant plus nab-paclitaxel with nab-paclitaxel monotherapy in patients with platinum-resistant ...

Some people stop nab-paclitaxel due to side effects so they may continue atezolizumab on its own. If this happens you may have it as an injection under your skin. When you are having this treatment ...

Dublin, March 27, 2025 (GLOBE NEWSWIRE) -- The "Paclitaxel Injection Market Report 2025"has been added to ResearchAndMarkets.com's offering. This report covers market characteristics, size and growth, ...

The certification is a milestone for Kexing Biopharm, whose first drug for cancer therapy, Paclitaxel for Injection (Albumin Bound) , can now be registered in the EU as the company overcomes the ...